Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: Final report of the Veterans Affairs randomized trial

被引:798
作者
Hammermeister, K
Sethi, GK
Henderson, WG
Grover, FL
Oprian, C
Rahimtoola, SH
机构
[1] Edward Hines Vet Adm Hosp, Edward Hines Vet Adm Med Ctr, VA Cooperat Studies Program, Coordinating Ctr 151k, Hines, IL 60141 USA
[2] Vet Adm Med Ctr, Denver, CO USA
[3] Univ Colorado, Hlth Sci Ctr, Denver, CO USA
[4] Vet Adm Med Ctr, Tucson, AZ 85723 USA
[5] Univ Arizona, Hlth Sci Ctr, Tucson, AZ USA
[6] Univ So Calif, LAC & USC Med Ctr, Los Angeles, CA USA
关键词
D O I
10.1016/S0735-1097(00)00834-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES The goal of this study was to compare long-term survival and valve-related complications between bioprosthetic and mechanical heart valves. BACKGROUND Different heart valves may have different patient outcomes. METHODS Five hundred seventy-five patients undergoing single aortic valve replacement (AVR) or mitral valve replacement (MVR) at 13 VA medical centers were randomized to receive a bioprosthetic or mechanical valve. RESULTS By survival analysis at 15 years, all cause mortality after AVR was lower with the mechanical valve versus bioprosthesis (66% vs. 79%, p = 0.02) but not after MVR. Primary valve failure occurred mainly in patients <65 years of age (bioprosthesis vs. mechanical, 26% vs. 0%, p < 0.001 for AVR and 44% vs. 4%, p = 0.0001 for MVR), and in patients greater than or equal to 65 years after AVR, primary valve failure in bioprosthesis versus mechanical valve was 9 +/- 6%, versus 0%, p = 0.16. Reoperation was significantly higher for bioprosthetic AVR (p = 0.004). Bleeding occurred more frequently in patients with mechanical valve. There were no statistically significant differences for other complications, including thromboembolism and all valve-related complications between the two randomized groups. CONCLUSIONS At 15 years, patients undergoing AVR had a better survival with a mechanical valve than with a bioprosthetic valve, largely because primary valve failure was virtually absent with mechanical valve. Primary valve failure was greater with bioprosthesis, both for AVR and MVR, and occurred at a much higher rate in those aged <65 years; in those aged greater than or equal to 65 years, primary valve failure after AVR was not significantly different between bioprosthesis and mechanical valve. Reoperation was more common for AVR with bioprosthesis. Thrombo-embolism rates were similar in the two valve prostheses, but bleeding was more common with a mechanical valve. (J Am Coil Cardiol 2000;36:1152-8) (C) 2000 by the American College of Cardiology.
引用
收藏
页码:1152 / 1158
页数:7
相关论文
共 23 条
[1]   AREVA: Multicenter randomized comparison of low-dose versus standard-dose anticoagulation in patients with mechanical prosthetic heart valves [J].
Acar, J ;
Iung, B ;
Boissel, JP ;
Samama, MM ;
Michel, PL ;
Teppe, JP ;
Pony, JC ;
LeBreton, H ;
Thomas, D ;
Isnard, R ;
deGevigney, G ;
Viguier, E ;
Sfihi, A ;
Hanania, G ;
Ghannem, M ;
Mirode, A ;
Nemoz, C ;
Bossard, N ;
Rolland, C ;
Lion, L ;
Marsault, C ;
Ferroir, JP ;
Conard, J ;
Laborde, JP ;
Logeais, Y ;
Delahaye, JP ;
Guerin, F ;
Lainee, R ;
Lesbre, JP .
CIRCULATION, 1996, 94 (09) :2107-2112
[2]  
Blackshear JL, 1996, LANCET, V348, P633
[3]   12-YEAR COMPARISON OF A BJORK-SHILEY MECHANICAL HEART-VALVE WITH PORCINE BIOPROSTHESES [J].
BLOOMFIELD, P ;
WHEATLEY, DJ ;
PRESCOTT, RJ ;
MILLER, HC .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (09) :573-579
[4]   ACC/AHA guidelines for the management of patients with valvular heart disease - A report of the American College of Cardiology American Heart Association Task Force on practice guidelines (Committee on Management of Patients with Valvular Heart Disease) [J].
Bonow, RO ;
Carabello, B ;
De Leon, AC ;
Edmunds, LH ;
Fedderly, BJ ;
Freed, MD ;
Gaasch, WH ;
Mckay, CR ;
Nishimura, RA ;
O'Gara, PT ;
O'Rourke, RA ;
Rahimtoola, SH .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 32 (05) :1486-1582
[5]   Twenty-year follow-up of the Hancock modified orifice porcine aortic valve [J].
Cohn, LH ;
Collins, JJ ;
Rizzo, RJ ;
Adams, DH ;
Couper, GS ;
Aranki, SF .
ANNALS OF THORACIC SURGERY, 1998, 66 (06) :S30-S34
[6]   RISK-FACTORS FOR COMPLICATIONS OF CHRONIC ANTICOAGULATION - A MULTICENTER STUDY [J].
FIHN, SD ;
MCDONELL, M ;
MARTIN, D ;
HENIKOFF, J ;
VERMES, D ;
KENT, D ;
WHITE, RH .
ANNALS OF INTERNAL MEDICINE, 1993, 118 (07) :511-520
[7]   Long-term performance of heart valve prostheses [J].
Grunkemeier, GL ;
Li, HH ;
Naftel, DC ;
Starr, A ;
Rahimtoola, SH .
CURRENT PROBLEMS IN CARDIOLOGY, 2000, 25 (02) :78-154
[8]  
GRUNKEMEIER GL, 1992, CURR PROBLEMS CARDIO, V26, P335
[9]  
GRUNKEMEIER GL, 1998, HURSTS HEART, P1851
[10]   COMPARISON OF OUTCOME AFTER VALVE-REPLACEMENT WITH A BIOPROSTHESIS VERSUS A MECHANICAL PROSTHESIS - INITIAL 5 YEAR RESULTS OF A RANDOMIZED TRIAL [J].
HAMMERMEISTER, KE ;
HENDERSON, WG ;
BURCHFIEL, CM ;
SETHI, GK ;
SOUCHEK, J ;
OPRIAN, C ;
CANTOR, AB ;
FOLLAND, E ;
KHURI, S ;
RAHIMTOOLA, S .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1987, 10 (04) :719-732